Does ADALIMUMAB Cause Therapy cessation? 1,712 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,712 reports of Therapy cessation have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.3% of all adverse event reports for ADALIMUMAB.
1,712
Reports of Therapy cessation with ADALIMUMAB
0.3%
of all ADALIMUMAB reports
0
Deaths
720
Hospitalizations
How Dangerous Is Therapy cessation From ADALIMUMAB?
Of the 1,712 reports, 720 (42.1%) required hospitalization, and 15 (0.9%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 1,712 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
SECUKINUMAB (620)
Which ADALIMUMAB Alternatives Have Lower Therapy cessation Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB